US 9649284
Treating critically ill patients with intravenous ibuprofen
granted A61KA61K31/192A61K31/197
Quick answer
US patent 9649284 (Treating critically ill patients with intravenous ibuprofen) held by Cumberland Pharmaceuticals Inc. expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/192, A61K31/197, A61K45/06, A61K9/0019